NBY logo

NovaBay Pharmaceuticals (NBY) Revenue

Annual Revenue

$14.73 M
+$322.00 K+2.24%

December 1, 2023

Summary

Performance

1-Year Change

+2.24%

3-Year Change

+48.24%

5-Year Change

+17.73%

15-Year Change

-19.22%

NBY Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.41%
NBY annual revenue is higher than 33.41% of companies in Healthcare sector

Analysts Estimate

$9.90 M
NBY annual revenue is currently +48.75% higher than the consensus analysts' forecast

High & Low

All-time High

$18.23 M
NBY annual revenue is currently -19.22% below its historical high of $18.23 million

3-Year Low

$10.20 M
NBY annual revenue is currently +44.32% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
NBY previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
NBY next annual earnings announcement has not yet been scheduled

OtherNBYprofitabilitymetrics:

Annual EPS

-$138.60
NBY annual earnings per share is -$138.60

Annual Net Income

-$9.64 M
NBY annual net profit is -$9.64 million

Annual Operating Profit

-$5.00 M
NBY annual operating income is -$5.00 million

Annual Gross Profit

$7.89 M
NBY annual gross profit is $7.89 million

Quarterly Revenue

$2.44 M
+$41.00 K+1.71%

September 1, 2024

Summary

Performance

3-Month Change

+1.71%

1-Year Change

-1.61%

3-Year Change

-30.93%

5-Year Change

-30.93%

NBY Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.5%
NBY quarterly revenue is higher than 24.5% of companies in Healthcare sector

Analysts Estimate

$2.50 M
NBY quarterly revenue is currently -2.36% lower than the consensus analysts' forecast

High & Low

All-time High

$7.49 M
NBY quarterly revenue is currently -67.42% below its historical high of $7.49 million

3-Year Low

$2.34 M
NBY quarterly revenue is currently +4.36% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$1.59 M
NBY quarterly gross profit is $1.59 million

Quarterly Operating Profit

-$1.06 M
NBY quarterly operating income is -$1.06 million

Quarterly Net Income

-$1.21 M
NBY quarterly net profit is -$1.21 million

Quarterly EPS

-$0.60
NBY quarterly earnings per share is -$0.60

TTM Revenue

$13.84 M
-$40.00 K-0.29%

September 1, 2024

Summary

Performance

3-Month Change

-0.29%

1-Year Change

+15.4%

3-Year Change

+3.76%

5-Year Change

+3.76%

NBY TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.75%
NBY TTM revenue is higher than 28.75% of companies in Healthcare sector

Analysts Estimate

$9.97 M
NBY TTM revenue is currently +38.83% higher than the consensus analysts' forecast

High & Low

All-time High

$18.23 M
NBY TTM revenue is currently -24.06% below its historical high of $18.23 million

3-Year Low

$9.38 M
NBY TTM revenue is currently +47.62% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYprofitabilitymetrics:

TTM Gross Profit

$7.87 M
NBY TTM gross profit is $7.87 million

TTM Operating Profit

-$5.59 M
NBY TTM operating income is -$5.59 million

TTM Net Income

-$10.12 M
NBY TTM net profit is -$10.12 million

TTM EPS

-$35.80
NBY TTM earnings per share is -$35.80

NBY Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.2%-1.6%+15.4%
3 y3 years+48.2%-30.9%+3.8%
5 y5 years+17.7%-30.9%+3.8%

NBY Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+44.3%-61.7%+4.4%-7.8%+47.6%
5 y5-yearat high+123.2%-61.7%+43.3%-7.8%+109.8%
alltimeall time-19.2%+1297.2%-67.4%+1884.5%-24.1%+6555.8%

NovaBay Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.44 M(+1.7%)
$13.84 M(-0.3%)
Jun 2024
-
$2.40 M(-8.8%)
$13.88 M(-7.6%)
Mar 2024
-
$2.63 M(-58.7%)
$15.02 M(+2.0%)
Dec 2023
$14.73 M(+2.2%)
$6.37 M(+156.8%)
$14.73 M(+22.7%)
Sep 2023
-
$2.48 M(-29.8%)
$12.00 M(-10.1%)
Jun 2023
-
$3.53 M(+51.1%)
$13.34 M(-1.0%)
Mar 2023
-
$2.34 M(-35.8%)
$13.47 M(-6.5%)
Dec 2022
$14.40 M(+41.2%)
$3.64 M(-4.8%)
$14.40 M(+3.4%)
Sep 2022
-
$3.83 M(+4.5%)
$13.93 M(+12.6%)
Jun 2022
-
$3.66 M(+11.9%)
$12.37 M(+14.1%)
Mar 2022
-
$3.27 M(+3.2%)
$10.84 M(+15.6%)
Dec 2021
$10.20 M(+2.7%)
$3.17 M(+40.1%)
$9.38 M(+15.9%)
Sep 2021
-
$2.27 M(+6.2%)
$8.09 M(+1.2%)
Jun 2021
-
$2.13 M(+18.0%)
$8.00 M(-18.8%)
Mar 2021
-
$1.81 M(-4.3%)
$9.85 M(-0.9%)
Dec 2020
$9.93 M(+50.5%)
$1.89 M(-13.0%)
$9.93 M(+1.9%)
Sep 2020
-
$2.17 M(-45.5%)
$9.75 M(+6.0%)
Jun 2020
-
$3.98 M(+110.6%)
$9.20 M(+31.4%)
Mar 2020
-
$1.89 M(+11.0%)
$7.00 M(+6.1%)
Dec 2019
$6.60 M(-47.2%)
$1.70 M(+5.5%)
$6.60 M(-22.5%)
Sep 2019
-
$1.61 M(-9.7%)
$8.52 M(-15.2%)
Jun 2019
-
$1.79 M(+20.0%)
$10.05 M(-9.1%)
Mar 2019
-
$1.49 M(-58.9%)
$11.05 M(-11.6%)
Dec 2018
$12.51 M(-31.4%)
$3.63 M(+15.4%)
$12.51 M(-17.7%)
Sep 2018
-
$3.14 M(+12.5%)
$15.20 M(-5.9%)
Jun 2018
-
$2.79 M(-5.2%)
$16.15 M(-7.6%)
Mar 2018
-
$2.95 M(-53.3%)
$17.48 M(-4.1%)
Dec 2017
$18.23 M(+53.2%)
$6.32 M(+54.4%)
$18.23 M(+14.0%)
Sep 2017
-
$4.09 M(-0.8%)
$15.99 M(+4.3%)
Jun 2017
-
$4.12 M(+11.4%)
$15.34 M(+10.5%)
Mar 2017
-
$3.70 M(-9.2%)
$13.88 M(+16.7%)
Dec 2016
$11.90 M(+171.6%)
$4.08 M(+18.6%)
$11.90 M(+25.8%)
Sep 2016
-
$3.44 M(+29.1%)
$9.46 M(+31.0%)
Jun 2016
-
$2.66 M(+54.9%)
$7.22 M(+29.8%)
Mar 2016
-
$1.72 M(+5.1%)
$5.56 M(+27.0%)
Dec 2015
$4.38 M
$1.64 M(+36.3%)
$4.38 M(+35.3%)
DateAnnualQuarterlyTTM
Sep 2015
-
$1.20 M(+19.0%)
$3.24 M(+47.9%)
Jun 2015
-
$1.01 M(+87.4%)
$2.19 M(+67.9%)
Mar 2015
-
$538.00 K(+9.6%)
$1.30 M(+23.7%)
Dec 2014
$1.05 M(-69.7%)
$491.00 K(+223.0%)
$1.05 M(-1.8%)
Sep 2014
-
$152.00 K(+23.6%)
$1.07 M(-46.9%)
Jun 2014
-
$123.00 K(-57.3%)
$2.02 M(-26.4%)
Mar 2014
-
$288.00 K(-43.5%)
$2.75 M(-21.1%)
Dec 2013
$3.48 M(-49.9%)
$510.00 K(-53.6%)
$3.48 M(-14.8%)
Sep 2013
-
$1.10 M(+29.6%)
$4.08 M(-38.4%)
Jun 2013
-
$848.00 K(-16.9%)
$6.62 M(-0.3%)
Mar 2013
-
$1.02 M(-8.4%)
$6.65 M(-4.3%)
Dec 2012
$6.95 M(-37.0%)
$1.11 M(-69.4%)
$6.95 M(-1.7%)
Sep 2012
-
$3.64 M(+318.1%)
$7.06 M(+14.0%)
Jun 2012
-
$871.00 K(-34.0%)
$6.19 M(-37.1%)
Mar 2012
-
$1.32 M(+7.3%)
$9.85 M(-10.6%)
Dec 2011
$11.02 M(+13.0%)
$1.23 M(-55.6%)
$11.02 M(-14.1%)
Sep 2011
-
$2.77 M(-38.8%)
$12.82 M(+5.7%)
Jun 2011
-
$4.53 M(+81.8%)
$12.14 M(+19.5%)
Mar 2011
-
$2.49 M(-18.0%)
$10.16 M(+4.2%)
Dec 2010
$9.75 M(-37.8%)
$3.04 M(+45.5%)
$9.75 M(-31.4%)
Sep 2010
-
$2.09 M(-18.1%)
$14.21 M(-7.4%)
Jun 2010
-
$2.55 M(+22.3%)
$15.35 M(+1.3%)
Mar 2010
-
$2.08 M(-72.2%)
$15.16 M(-3.4%)
Dec 2009
$15.68 M(+133.3%)
$7.49 M(+132.4%)
$15.68 M(+51.0%)
Sep 2009
-
$3.22 M(+36.8%)
$10.39 M(+18.6%)
Jun 2009
-
$2.36 M(-9.7%)
$8.76 M(+11.7%)
Mar 2009
-
$2.61 M(+18.9%)
$7.84 M(+16.6%)
Dec 2008
$6.72 M(+13.7%)
$2.20 M(+37.9%)
$6.72 M(+11.2%)
Sep 2008
-
$1.59 M(+10.4%)
$6.05 M(+2.5%)
Jun 2008
-
$1.44 M(-3.4%)
$5.90 M(-0.4%)
Mar 2008
-
$1.49 M(-1.9%)
$5.92 M(+0.2%)
Dec 2007
$5.91 M(+285.7%)
$1.52 M(+5.3%)
$5.91 M(+3.4%)
Sep 2007
-
$1.44 M(-1.4%)
$5.72 M(+27.6%)
Jun 2007
-
$1.47 M(-1.2%)
$4.48 M(+48.6%)
Mar 2007
-
$1.48 M(+11.9%)
$3.02 M(+96.7%)
Dec 2006
$1.53 M
$1.32 M(+537.0%)
$1.53 M(+637.0%)
Sep 2006
-
$208.00 K
$208.00 K

FAQ

  • What is NovaBay Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals annual revenue year-on-year change?
  • What is NovaBay Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals quarterly revenue year-on-year change?
  • What is NovaBay Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals TTM revenue year-on-year change?

What is NovaBay Pharmaceuticals annual revenue?

The current annual revenue of NBY is $14.73 M

What is the all time high annual revenue for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high annual revenue is $18.23 M

What is NovaBay Pharmaceuticals annual revenue year-on-year change?

Over the past year, NBY annual revenue has changed by +$322.00 K (+2.24%)

What is NovaBay Pharmaceuticals quarterly revenue?

The current quarterly revenue of NBY is $2.44 M

What is the all time high quarterly revenue for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high quarterly revenue is $7.49 M

What is NovaBay Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, NBY quarterly revenue has changed by -$40.00 K (-1.61%)

What is NovaBay Pharmaceuticals TTM revenue?

The current TTM revenue of NBY is $13.84 M

What is the all time high TTM revenue for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high TTM revenue is $18.23 M

What is NovaBay Pharmaceuticals TTM revenue year-on-year change?

Over the past year, NBY TTM revenue has changed by +$1.85 M (+15.40%)